The FDA has also warned practitioners and consumers to be on the lookout for fake versions of Ozempic, while the drug manufacturer, Novo Nordisk, filed a total of 21 lawsuits against entities for engaging in harmful and deceptive practices related to the marketing and sales of purported semaglutide products
Acute illness may require temporary dose adjustment or suspension of GLP-1 therapy, particularly if you cannot maintain adequate fluid intake
He explained that the benefits need to be weighed against potential side effects, adding that investigations of side effects become especially important given the broad range of people this medicine and others like it could help
Any stacking approach requires understanding the interactions, timing, and dosing adjustments for each compound
Same incretin pathway Little added efficacy More cost More polypharmacy Rule in practice: stop DPP-4 inhibitor before starting semaglutide unless there is a very unusual reason not to